1-2 of 2
Liang Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Low-Dose Apatinib Combined with Chemotherapy as Second-Line Treatment for Advanced Gastric Cancer: A Meta-Analysis

Subject Area:
Further Areas , Oncology , Pharmacology
Liang Wang, Juyuan Li, Huamin Chen
Journal: Chemotherapy
Chemotherapy (2024) 69 (1): 11–22.
https://doi.org/10.1159/000531524
Published Online: 20 June 2023
View article titled, Efficacy and Safety of Low-Dose Apatinib Combined with Chemotherapy as Second-Line Treatment for Advanced Gastric Cancer: A Meta-Analysis
Open the PDF for Efficacy and Safety of Low-Dose Apatinib Combined with Chemotherapy as Second-Line Treatment for Advanced Gastric Cancer: A Meta-Analysis in another window
Journal Articles

Overall Response to First-Line Tyrosine Kinase Inhibitor and Second-Line Chemotherapy Is Predictive of Survival Outcome in Epidermal Growth Factor Receptor-Mutated Adenocarcinoma

Subject Area:
Further Areas , Oncology , Pharmacology
Scott Chih-Hsi Kuo, Ping-Chih Hsu, Chih-Hung Chen, Chih-Teng Yu, Chih-Liang Wang, Fu-Tsai Chung, Shu-Min Lin, Yu-Lun Lo, Tse-Ching Chen, Chien-Ying Liu, Cheng-Ta Yang
Journal: Chemotherapy
Chemotherapy (2015) 60 (3): 201–210.
https://doi.org/10.1159/000371735
Published Online: 02 April 2015
View article titled, Overall Response to First-Line Tyrosine Kinase Inhibitor and Second-Line Chemotherapy Is Predictive of Survival Outcome in Epidermal Growth Factor Receptor-Mutated Adenocarcinoma
Open the PDF for Overall Response to First-Line Tyrosine Kinase Inhibitor and Second-Line Chemotherapy Is Predictive of Survival Outcome in Epidermal Growth Factor Receptor-Mutated Adenocarcinoma in another window